Searched for
GASTROINTESTINAL DRUG
Quote of the day from 'father' of stress research Hans Seyle: 'Stress is not something to be avoided. Complete freedom from stress is...'; lessons on how to manage stress and anxiety from famous Canadian scholarOver 90 years ago, Hans Selye challenged the notion that stress is inherently negative. He argued that stress is a natural part of life, es...- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...
- Cancer drug makers seek 50% price hike as platinum surge hits production viabilityLocal drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...
- Pharma market in good health; lifestyle diseases may be risingThe other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the therapy segment, the...
- Pharma market picks up pace, sees 10% value growth in NovIndia's pharmaceutical market rebounded in November with 9.9% value growth and 3.1% volume growth. Key therapy areas like cardiac, gastroin...
- Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian marketLupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The ...
- Dr Reddy's inks licensing pact with Takeda to sell gastrointestinal drugNew Delhi: Dr Reddy's Laboratories, a Hyderabad-based firm, and Takeda Pharmaceutical entered a non-exclusive licensing pact to market 10mg...
- Zydus inks licensing pact with Takeda to sell GERD drug"With a rich legacy in marketing gastrointestinal therapies in India, we have been offering different breakthrough clinical options across ...
- As monsoon sets in, respiratory, malaria drugs see demand riseThe onset of the monsoon in June led to a significant increase in sales of drugs for respiratory, anti-infective, anti-malaria, and gastroi...
- Sun Pharma inks pact with Takeda to introduce gastrointestinal drug in IndiaSun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in...
- New study warns of serious side effects from popular weight loss drugs Wegovy and Ozempic, finds they may paralyse stomachA recent US study has found that weight loss medications like Wegovy and Ozempic may increase the risk of abdominal paralysis, characterize...
- Drug sales reveal our lifestyle woesIndians spent over Rs 1,36,000 cr on medicines in last one year ending September 2019. People spent over Rs 17,000 cr on cardiac drugs, aro...
- Gastrointestinal drug sales show highest incremental gain in a yearAnti-infective cough and cold medication still tops the chart, with sales totalling Rs 14,735 crore in the domestic organised retail market.
- HC allows sale of 2 banned drugs to exhaust stockCompanies cannot dispatch new batches or resume production. The association will now move the court to remove the ban on the drugs altogeth...
Load More
